HHEX promotes myeloid transformation in cooperation with mutant ASXL1
Reina Takeda(The University of Tokyo), Toshio Kitamura(National Agriculture and Food Research Organization), Toshiya Inaba(Hiroshima University), Taishi Yonezawa(The University of Tokyo), Moe Tamura(The University of Tokyo), Yasutaka Hayashi(Tokyo Medical and Dental University), Tsuyoshi Fukushima(Harvard University), Tatsuhiro Shibata(The University of Tokyo), Kenta Nakai(The University of Tokyo), Satoshi Yamazaki(Institute for Stem Cell Biology and Regenerative Medicine), Satoshi Yamasaki(St. Mary’s Hospital), Akihiko Yokoyama(Chiba Cancer Center), Shuhei Asada(The University of Tokyo), Daichi Inoue(Tokyo University of Science), H. Becker(University of Tsukuba), Akinori Kanai(Frontier Medical College), Tomofusa Fukuyama(The University of Tokyo), Jaroslaw P. Maciejewski(Cleveland Clinic), Susumu Goyama(The University of Tokyo), Sung‐Joon Park(Korea University), Hiroaki Honda(Tokyo Women's Medical University), Akiko Matsumoto(The University of Tokyo), Courtney E. Hershberger(Cleveland Clinic Lerner College of Medicine), Yosuke Tanaka(University of Occupational and Environmental Health Japan), Valeria Visconte(Cleveland Clinic)
Cited by 18
Related Papers
Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
|Nature Medicine|2019|1.5k
Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer
|Nature Medicine|2019|1.4k
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
|Cancer Cell|2012|1.4k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k